Pulmonx (NASDAQ:LUNG) Upgraded by Zacks Investment Research to Buy

Pulmonx} stock has undergone multiple analysts rating changes in the recent past.  Pulmonx Upgraded by Zacks Investment Research on 10/20/2021. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

View More Pulmonx (NASDAQ:LUNG) Upgraded by Zacks Investment Research to Buy